Health economic & outcomes research

Health economic & outcomes research

As healthcare system budgets tighten and payers and regulators continue to focus on the patient’s perspective, health economics and outcomes research (otherwise non-interventional studies) is key to products’ success. Budget impact and cost effectiveness are crucial considerations for formulary acceptance and market access. Moreover, real-world evidence for the clinical effectiveness of products as well as patients’ health-related quality-of-life and other patient-reported outcomes (PROs) are becoming increasingly important for registration, reimbursement and marketing of new treatments. Generating relevant economic and humanistic evidence for a variety of different stakeholders, health authorities and technology assessment agencies requires a multidisciplinary approach to the design, execution and analysis of data.

Using internal resources and external partners, our Health Economics and Outcomes Research (HEOR) team can provide:

  • HEOR study consultation and design
  • Secondary database analysis and statistical modeling
  • Interpretation and insights that go far beyond reports

We can meet all our clients HEOR needs:

  • Economic evaluation studies
  • Real world evidence generation
  • Evidence Synthesis

Our services in Health Economic & Outcomes Research include:

Therapeutic expertise

We have strong experience in the following areas
  • Surgery/Orthopedics
  • Cardiovascular diseases
  • Infectious diseases
  • Public Health/ Pediatrics
  • Psoriasis
  • Multiple sclerosis
  • Psoriatic arthritis
  • Chronic angina pectoris
  • Antihypertensive therapy
  • Venous thromboembolism
  • Atrial fibrillation
  • Chronic heart failure
  • Diabetes
  • Atherothrombosis
  • Cardiac devices